Evonik Industries AG
DUS:EVK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Evonik Industries AG
DUS:EVK
|
DE |
|
N
|
NWAI Dom Maklerski SA
WSE:NWA
|
PL |
|
ASR Nederland NV
OTC:ARNNY
|
NL |
Evonik Industries AG
Evonik Industries AG is a German specialty chemicals company. It makes ingredients and materials that other companies use to improve their own products, such as additives for coatings and plastics, feed amino acids for animal nutrition, and specialty materials for things like adhesives, cosmetics, and medical products. Its customers are mainly industrial manufacturers, agriculture and animal feed producers, and consumer-goods companies that need consistent, high-performance chemical inputs. The company sells these products through long-term supply relationships and technical service, rather than one-off consumer sales. It makes money by producing and selling specialty chemicals that are often tied to specific customer formulations or production processes, which can create recurring demand and switching costs. In many cases, Evonik is a supplier that sits in the middle of the value chain, helping its customers improve performance, efficiency, or product quality. What makes Evonik different is its focus on specialized chemistry instead of basic bulk chemicals. That means it often competes on product know-how, reliability, and close customer support, not just on price. This gives the business a role as a behind-the-scenes partner to industrial and consumer brands that need tailored chemical ingredients.
Evonik Industries AG is a German specialty chemicals company. It makes ingredients and materials that other companies use to improve their own products, such as additives for coatings and plastics, feed amino acids for animal nutrition, and specialty materials for things like adhesives, cosmetics, and medical products. Its customers are mainly industrial manufacturers, agriculture and animal feed producers, and consumer-goods companies that need consistent, high-performance chemical inputs.
The company sells these products through long-term supply relationships and technical service, rather than one-off consumer sales. It makes money by producing and selling specialty chemicals that are often tied to specific customer formulations or production processes, which can create recurring demand and switching costs. In many cases, Evonik is a supplier that sits in the middle of the value chain, helping its customers improve performance, efficiency, or product quality.
What makes Evonik different is its focus on specialized chemistry instead of basic bulk chemicals. That means it often competes on product know-how, reliability, and close customer support, not just on price. This gives the business a role as a behind-the-scenes partner to industrial and consumer brands that need tailored chemical ingredients.
Strong quarter: Evonik said Q2 was the best quarterly result in 4 years, with adjusted EBITDA up 24% year over year to EUR 630 million and above expectations.
Outlook raised: Management reiterated the upgraded full-year outlook that lifted the midpoint by EUR 250 million and said Q3 should be at least as strong as Q2, with some normalization expected in Q4.
Methionine strength: Methionine remained a major earnings driver, with management saying Q3 should be the best methionine quarter of the year and that the business should outperform most expectations in 2026.
Cost cuts expanded: Evonik extended its Tailor-made restructuring program and now plans to reduce about 3,200 more positions between 2027 and 2029, on top of earlier reductions.
Cash improved: Cash generation improved significantly, helping support the full-year target of around 40% cash conversion and reducing pressure on net financial debt seasonally.
Capital use: Management said the new dividend policy starts in May 2027 and that a share buyback is not currently on the agenda.